GGrantIndex
Sort

17,054 grants matching genome editing

Development of Next-Generation Blood-to-barcode (B2B) chip for In Vivo CRISPR-Based Discovery of Metastasis Regulators

$625,914
Shana O Kelley · Northwestern University · R01 · FY2023 · CA

Development of Next-Generation Blood-to-barcode (B2B) chip for In Vivo CRISPR-Based Discovery of Metastasis Regulators

$625,914
Shana O Kelley · Northwestern University · R01 · FY2025 · CA

Implementing genomic medicine in clinical care of deaf patients

$625,724
Xue Z Liu · University Of Miami School Of Medicine · R01 · FY2022 · DC

Family Study of Carotid Atherosclerosis and Stroke Risk

$625,704
Tatjana Rundek · University Of Miami School Of Medicine · R01 · FY2019 · NS

Developing gene editing platforms for retinal degeneration.

$625,649
Gaurav Sahay · Oregon State University · R01 · FY2024 · EY

In vivo prime editing for precision cancer mouse models

$625,607
Wen Xue · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · CA

Molecular Regulation of LDL Receptor Expression

$625,479
Brian T Emmer · University Of Michigan At Ann Arbor · R01 · FY2024 · HL

Multi-organism platform for functional assessment of human birth defect associated genomic variants

$625,432
Lilianna Solnica-Krezel · Washington University · R01 · FY2025 · HD

Epigenetic mechanisms of sustained transcription across cocaine abstinence

$625,371
Elizabeth A Heller · University Of Pennsylvania · R01 · FY2025 · DA

Elucidating Genotype-Phenotype Relationship of Polygenic Dilated Cardiomyopathies

$625,285
Joseph C Wu · Stanford University · R01 · FY2020 · HL

The Role of Coxiella Effector Proteins in Infection and Disease

$625,276
Craig R. Roy · Yale University · R56 · FY2024 · AI

Cellular and Genetic Defects in Keratoconus

$625,118
Shukti Chakravarti · New York University School Of Medicine · R01 · FY2023 · EY

Efficient Sendai virus mediated CRISPR/Cas9 gene editing to protect hematopoietic stem cells from HIV

$625,091
Dong Sung An · University Of California Los Angeles · R01 · FY2020 · AI

Efficient Sendai virus mediated CRISPR/Cas9 gene editing to protect hematopoietic stem cells from HIV

$625,091
Dong Sung An · University Of California Los Angeles · R01 · FY2021 · AI

CRISPR-Cas13 gene therapy and RNA editing for Facioscapulohumeral muscular dystrophy (FSHD)

$624,920
Scott Q Harper · Research Inst Nationwide Children'S Hosp · R01 · FY2021 · AR

Investigation of Reactions of Physiological Importance

$624,765
Paul R Schimmel · Scripps Research Institute, The · R01 · FY2009 · GM

Epigenomic Reprogramming in Patient Derived Models of Colorectal Cancer

$624,587
Shiaowen David Hsu · Duke University · U01 · FY2022 · CA

Genetic and Functional Mechanisms in Citrate Transporter Disorder associated with SLC13A5

$624,559
Stephen L. Helfand · Brown University · R01 · FY2025 · NS

Modeling BRAF-fusion driven pediatric brain tumors in the mouse

$624,546
Andrea Ventura · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA

Modeling BRAF-fusion driven pediatric brain tumors in the mouse

$624,546
Andrea Ventura · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA

Modeling BRAF-fusion driven pediatric brain tumors in the mouse

$624,546
Andrea Ventura · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA

Engineering T Cell Adoptive Therapy for Glioblastoma

$624,543
Gavin Peter Dunn · Massachusetts General Hospital · R01 · FY2024 · NS

Quantitative analysis of mucociliary clearance in airway ciliopathies

$624,431
Amy Leanne Ryan · University Of Southern California · R01 · FY2021 · HL

FEN1-Nuclease-Targeted Therapy for Ewing Sarcoma

$624,288
Richard D Kolodner · University Of California, San Diego · R01 · FY2025 · CA

Regulation and function of dsRNAs derived from retrotransposable elements in AD

$624,184
Xinshu Grace Xiao · University Of California Los Angeles · R01 · FY2025 · AG